Three weeks into the country’s second nationwide lockdown, France—along with other parts of Europe—is beginning to see the first signs of the curbing of coronavirus spread, though officials say it’s still too early to pull back all restrictions and that the French people must stay vigilant.
People wearing face masks walk near the Eiffel Tower in Paris, France in October.
Xinhua News Agency/Getty Images
Reuters reported Thursday that the number of coronavirus patients being treated in French hospitals dropped to 32,345, reportedly the third day in a row that hospitalizations fell as the number of patients in intensive care for coronavirus also declined since the previous day
France boasts a much slower spread of the disease than in October, when the second lockdown was put in effect: On Thursday, the country registered 21,150 new infections, a steep drop from the more than 50,000 cases reported in one day the week President Emmanuel Macron announced the latest lockdown.
The hopeful news has led to calls for restrictions on businesses to be scaled back so shopkeepers can take advantage of the pre-holiday shopping season to make up for lost sales, AFP reported.
While Macron and his ministers did meet this week to discuss possibly lifting some crackdowns in early December, French media have reported it’s unlikely all restrictions will be pulled anytime soon.
What To Watch
Macron will reportedly address the French coronavirus outbreak and the government response at some point next week, AFP said, especially pertaining to guidelines for traveling to visit friends and family ahead of Christmas.
Despite the recent decline in new infections and hospitalizations, France is still one of the hardest hit countries in the world by the coronavirus pandemic. According to a tracker kept by Johns Hopkins University, France has counted more than 2 million total cases since the beginning of the pandemic. With more than 27,000 reported coronavirus deaths, it is also home to the seventh most deadly outbreak in the world, according to Johns Hopkins.